REVVITY, INC Proceeds from Derivative Instrument, Investing Activities
REVVITY, INC (RVTY) reported Proceeds from Derivative Instrument, Investing Activities of $0 for the 12-month period ending 2019-12-29, per its 10-K filed 2020-02-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities · last filed 2020-02-25
- REVVITY, INC proceeds from derivative instrument, investing activities for the quarter ending 2018-12-30 was $0.00.
- REVVITY, INC proceeds from derivative instrument, investing activities for the quarter ending 2017-12-31 was -$23.88M.
- REVVITY, INC proceeds from derivative instrument, investing activities for the quarter ending 2017-01-01 was $0.00.
- REVVITY, INC proceeds from derivative instrument, investing activities for fiscal 2019 was $0.00.
- REVVITY, INC proceeds from derivative instrument, investing activities for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- REVVITY, INC proceeds from derivative instrument, investing activities for fiscal 2017 was $36.54M.
- REVVITY, INC proceeds from derivative instrument, investing activities for fiscal 2017 was $0.00.
| Period end | Proceeds from Derivative Instrument, Investing Activities 3 month | Proceeds from Derivative Instrument, Investing Activities 9 month | Proceeds from Derivative Instrument, Investing Activities 12 month |
|---|---|---|---|
| 2019-12-29 | $0.00 10-K · filed 2020-02-25 | ||
| 2018-12-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 10-K · filed 2020-02-25 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-06 | ||
| 2017-12-31 | -$23.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $36.54M 10-K · filed 2020-02-25 | |
| 2017-10-01 | $60.42M 10-Q · filed 2018-11-06 | ||
| 2017-01-01 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $0.00 10-K · filed 2019-02-26 | |
| 2016-10-02 | $0.00 10-Q · filed 2017-11-07 | ||
| 2016-01-03 | $0.00 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |